The {pharmaceutical industry is rapidly exploring alternative treatment approaches for obesity , and the arrival of semaglutide 10mg injectables represents a significant change. Clinicians are now evaluate the possible benefits and drawbacks associated with this higher potency product, especially in relation to existing less potent semaglutide prod